SCHEMBL1290989

SCHEMBL1290989

CC1(C)OB(C(=O)c2ccccc2)OC1(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 1/20 0.45
TSHR P16473 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
CYP3A4 P08684 2/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
PARP1 P09874 1/20 0.41
CYP2C19 P33261 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LPL P06858 1/20 0.40
LIPG Q9Y5X9 1/20 0.40
CES1 P23141 6/20 0.39
CES2 O00748 5/20 0.39
ALDH1A1 P00352 2/20 0.39
DAO P14920 1/20 0.39
NAPRT Q6XQN6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6236165 0.79 LPL (0.42) P4HBTSHRCYP3A4MAPTLPL
SCHEMBL6236173 0.79 LPL (0.42) P4HBTSHRCYP3A4MAPTLPL
SCHEMBL6236171 0.79 LPL (0.42) P4HBTSHRCYP3A4MAPTLPL
SCHEMBL3555946 0.76 LPL (0.40) P4HBMAPTLPLLIPGALDH1A1
SCHEMBL5704180 0.76 P4HB (0.45) P4HBTSHRTDP1CYP3A4MAPT
SCHEMBL5704185 0.76 P4HB (0.45) P4HBTSHRTDP1CYP3A4MAPT
SCHEMBL6236708 0.75 P4HB (0.46) P4HBTSHRTDP1CYP3A4MAPT
SCHEMBL6236713 0.75 P4HB (0.46) P4HBTSHRTDP1CYP3A4MAPT
SCHEMBL6236711 0.75 P4HB (0.46) P4HBTSHRTDP1CYP3A4MAPT
SCHEMBL18920424 0.74 LPL (0.39) P4HBTSHRHSD17B10LPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012045194-A1 BENZODIAZEPINONES AS FAK INHIBITORS FOR TREATMENT OF CANCER ABBOTT LABORATORIES (US) 2012-04-12 WO disclosed